Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Free Cash Flow: 2010-2021

Historic Free Cash Flow for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2021 value amounting to -$4.7 million.

  • Neurocrine Biosciences' Free Cash Flow fell 105.22% to -$4.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $233.1 million, marking a year-over-year increase of 7.12%. This contributed to the annual value of $557.2 million for FY2024, which is 54.09% up from last year.
  • As of Q4 2021, Neurocrine Biosciences' Free Cash Flow stood at -$4.7 million, which was down 108.38% from $56.1 million recorded in Q3 2021.
  • Over the past 5 years, Neurocrine Biosciences' Free Cash Flow peaked at $114.2 million during Q2 2020, and registered a low of -$116.4 million during Q1 2019.
  • Over the past 3 years, Neurocrine Biosciences' median Free Cash Flow value was $71.2 million (recorded in 2019), while the average stood at $48.6 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 193.38% in 2017, then soared by 566.88% in 2018.
  • Neurocrine Biosciences' Free Cash Flow (Quarterly) stood at $38.2 million in 2017, then climbed by 16.48% to $44.5 million in 2018, then spiked by 112.85% to $94.7 million in 2019, then dropped by 4.96% to $90.0 million in 2020, then tumbled by 105.22% to -$4.7 million in 2021.
  • Its last three reported values are -$4.7 million in Q4 2021, $56.1 million for Q3 2021, and $98.9 million during Q2 2021.